|
Celgene's Current Quazar Clinical Trial of Vidaza pill form...
There is a clinical trial in progress called CC-486 (Oral Azacitidine).
"QUAZAR Study for Lower-Risk MDS Patients – A clinical research trial sponsored by Celgene Corporation. This is a study for people with MDS who need blood transfusions due to low red blood cell counts (called anemia) and low platelet counts (called thrombocytopenia)."
It's meant for patients with low-risk MDS; however, it may prove helpful also for those with higher blasts. 
https://www.celgeneclinicaltrials.com/quazar-mds
__________________
Ric: Low-risk MDS (blasts <4%); 4 cycles Revlimid no positive response; PRBC transfusion dependent; so far, 392'units' over 8 3/4 years; BMB #4 (15/04/01) shows evolution to AML (blasts 20-30%  ) 47,XY,del(5) (q22q35),+21[24][cp24]/46,XY(1).
|